AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2018
Mar 9, 2018
32870_dirs_2018-03-09_a3148fb1-f6e3-4eee-a9a9-91b77b25c6eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-03-07
Reporting Person: Havey Adam (EVP, Business Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-07 | Common Stock | M | 6573 | $22.03 | Acquired | 39573 | Direct |
| 2018-03-07 | Common Stock | F | 2843 | $50.43 | Disposed | 36730 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-07 | Stock Option (Right to Buy) | $22.03 | M | 6573 | Disposed | 2018-03-14 | Common Stock (6573) | Direct |
Footnotes
F1: Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise.
F2: Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
F3: The option vested in three equal installments in March 2012, March 2013 and March 2014. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.